Novartis suspended trading after the DEL-DESIRAN drug trial was thwarted, and recently fell 8.8%.

Zhitongcaijing · 1d ago
Novartis suspended trading after the DEL-DESIRAN drug trial was thwarted, and recently fell 8.8%.